Pharmacology

Action Mechanism of Action Reference
INHIBITOR NKG2-A/NKG2-B type II integral membrane protein inhibitor PubMed Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 2 D002289 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Genital Neoplasms, Female 1 D005833 ClinicalTrials
Head and Neck Neoplasms 1 D006258 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 1 D000077195 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297787
FDA SRS 3ZXZ2V0588